Skip to main content
Fig. 2 | BMC Pediatrics

Fig. 2

From: Dose titration of osmotic release oral system methylphenidate in children and adolescents with attention-deficit hyperactivity disorder: a retrospective cohort study

Fig. 2

Sankey diagrams of OROS-MPH dose titration patterns among ADHD patients with at least one titration: a Child OROS-MPH users in the US cohort (N = 30,237); b Adolescent OROS-MPH users in the US cohort (N = 11,365); c Child OROS-MPH users in the Japanese cohort (N = 1640); d Adolescent OROS-MPH users in the Japanese cohort (N = 578). ‘1_18’ refers to patients whose initial OROS-MPH daily dose level was 18 mg/day, ‘2_27’ refers to patients whose second OROS-MPH daily dose level was 27 mg/day, and so on

Back to article page

BMC Pediatrics

ISSN: 1471-2431

Contact us